FDA
-
-
-
-
-
-
-
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
-
-
-
-
-
-
-
Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs
-
-
-
-
-
322,220 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

